Integrated Analysis of Cell Cycle–Related and Immunity-Related Biomarker Signatures to Improve the Prognosis Prediction of Lung Adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD) is a leading malignancy and has a poor prognosis over the decades. LUAD is characterized by dysregulation of cell cycle. Immunotherapy has emerged as an ideal option for treating LUAD. Nevertheless, optimal biomarkers to predict outcomes of immunotherapy is sti...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Fangyu, Song, Jiahang, Ye, Ziqi, Xu, Bing, Cheng, Hongyan, Zhang, Shu, Sun, Xinchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212041/
https://www.ncbi.nlm.nih.gov/pubmed/34150632
http://dx.doi.org/10.3389/fonc.2021.666826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212041/
https://www.ncbi.nlm.nih.gov/pubmed/34150632
http://dx.doi.org/10.3389/fonc.2021.666826

Ejemplares similares